<DOC>
	<DOC>NCT00307658</DOC>
	<brief_summary>The aim of this study is to study the efficacy of intravenous immunoglobulins for inducing remission in patients relapsing of systemic vasculitides.</brief_summary>
	<brief_title>Intravenous Immunoglobulin After Relapse in Vasculitis</brief_title>
	<detailed_description>The aim of this study will assess the effects of intravenous immunoglobulin in ANCA+ vasculitides (Microscopic Polyangiitis, Wegener’s granulomatosis and Churg-Strauss syndrome) who relapse under corticosteroid and immunosuppressant therapies or after one year post treatment.</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Immunoglobulins, Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho(D) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<criteria>Wegener’s granulomatosis, Microscopic polyangiitis and ChurgStrauss syndrome (satisfying ACR or chapel Hill classification) relapsing either under corticosteroid and immunosuppressant therapies or after one year post treatment Age &gt; 18 years old Written informed consent Systemic vasculitides not previously treated with corticosteroid and immunosuppressant(s) Systemic vasculitides treated with corticosteroids and immunosuppressant therapies, but with treatment cessation more than 12 months ago Polyarteritis nodosa Absence of poor prognosis criteria (according to FFS) Nephritis ± renal impairment Cancer or malignancy Psychiatric disease, lack of compliance Age under 18 years old Lack of written informed consent Other vasculitides (post viral infection and skin localisation)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2003</verification_date>
	<keyword>ANCA associated Vasculitides</keyword>
	<keyword>Relapse</keyword>
	<keyword>intravenous Immunoglobulins</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Immunosuppressant</keyword>
</DOC>